Dennis Smith Jr., MD
Dr. Smith possesses over 35 years of experience in healthcare management, pathology, laboratory medicine, outreach laboratory businesses, molecular diagnostics, and blood banking.
Dr. Smith is a board-certified clinical and anatomic pathologist and transfusion medicine specialist. His professional career includes serving on the executive management team and Board of Directors of AmeriPath, Inc. (NASDAQ: PATH). While at AmeriPath, Dr. Smith’s positions included Chief Medical Officer, Executive Vice-President of Genomic Strategies, and Executive Director of AmeriPath’s Center for Advanced Diagnostics.
Previously, Dr. Smith has held board seats at Immucor, Inc. (NASDAQ: BLUD), Clarient, Inc. (NASDAQ:CLRT), the American Association of Blood Banks (President), the National Blood Foundation (Chairman), and RedPath Integrated Pathology, Inc., a venture-backed, early-stage molecular diagnostics company where he served as CEO and led a successful sale of the company to PDI, Inc. He is an Emeritus member of the Committee of Visitors for Vanderbilt University School of Engineering, from which he graduated summa cum laude.
Dr. Smith received his BS from Vanderbilt and his MD from the University of Tennessee.
Discover how seeQer informs patients and transforms practice.
Schedule a seeQer demonstration of benefits verifications, cost assessments, and other essential tasks in the platform. Learn how seeQer can help your organization reduce administrative burden, transform cumbersome processes, and provide transparency that empowers patients in a complex and ever-changing industry.